Journal
TOXICOLOGICAL SCIENCES
Volume 126, Issue 2, Pages 478-486Publisher
OXFORD UNIV PRESS
DOI: 10.1093/toxsci/kfs008
Keywords
nanoparticles; prenatal; inhalation; cadmium; developmental; maternal exposure
Categories
Funding
- National Institute of Environmental Health Sciences (NIEHS) [ES017427, T32 ES007324]
- NYU NIEHS Center [ES000260]
Ask authors/readers for more resources
One industrially important metal oxide nanoparticle (NP) is cadmium oxide (CdO). A study was performed using timed-pregnant CD-1 mice to determine if Cd associated with inhaled CdO NP could reach the placenta and adversely affect the developing fetus and/or neonate. Pregnant mice were exposed by inhalation either every other day to 100 mu g of freshly generated CdO/m(3) (exposure 1) or daily to 230 mu g CdO/m(3) (exposure 2). In each exposure, mice were exposed to CdO NP or carrier gas (control) for 2.5 h from 4.5 days post coitus (dpc) through 16.5 dpc. At 17.5 dpc, fetuses and placentas from both exposures 1 and 2 were collected, measured, and weighed. A subgroup from the second exposure was allowed to give birth, and neonates were weighed daily until weaning. Cadmium in the uterus and placenta, as well as in other maternal organs, was elevated in NP-treated mice, but was undetectable in fetuses at 17.5 dpc. Daily inhalation of 230 mu g CdO NP/m(3) decreased the incidence of pregnancy (i.e., no evidence of implantation) by 23%, delayed maternal weight gain, altered placental weight, and decreased fetal length, as well as delayed neonatal growth. This study demonstrates that inhalation of CdO NP during pregnancy adversely affects reproductive fecundity and alters fetal and postnatal growth of the developing offspring.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available